Journal profile · PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES
Antimicrobial Resistance and Infection Control
ISSN 2047-2994 · BioMed Central · ENGLAND · Founded 2012
Antimicrobial Resistance and Infection Control: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.14; fully open access; APC about USD 3,290; median 148 days to acceptance (106 articles, last 24 months); 173 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Antimicrobial Resistance and Infection Control is published by BioMed Central and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Use and Resistance, Infection Control in Healthcare and Antibiotic Resistance in Bacteria, together about 42% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Antimicrobial Resistance and Infection Control is an open access, peer-reviewed journal that focuses on the prevention of healthcare-associated infections and antimicrobial resistance. This is accomplished through the publication of innovative, high-quality original research from low-, middle-, and high-income countries. The journal welcomes submissions from the broad field of healthcare epidemiology and infection prevention and control. While the journal’s primary focus is on infection prevention in healthcare, submissions from other fields or settings (e.g., public health, One Health, or antimicrobial stewardship) will also be considered where these relate directly to the prevention of antimicrobial resistance or healthcare-associated infections in humans. Given the stated aims and scope, the journal does not routinely consider submissions relating to the following topics: Single-point and single-centre estimates of antimicrobial resistance rates, unless they illustrate new developments of broad interest to those working in healthcare epidemiology and infection prevention. Animal health or the environment, unless these explore a direct relationship to human health (One Health principle). Clinical diagnosis or treatment of infectious diseases. Laboratory-based research and microbiological/genomic aspects of AMR without implications for clinical infection prevention.
From the journal's Aims & Scope
Research area (LetPub): PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES
Editor-in-chief Ermira TartariPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 12, Switzerland 9, United Kingdom 5, Germany 5, France 4 (74 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Use and ResistanceImmunology and Microbiology14.5%
- Infection Control in HealthcareMedicine13.9%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology13.6%
- Nosocomial Infections in ICUMedicine9.6%
- Antimicrobial Resistance in StaphylococcusMedicine5.4%
- Surgical site infection preventionMedicine5%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology4.1%
- Infection Control and VentilationMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
| Minor | Microbiology | Zone 2 |
| Minor | Public, Environmental & Occupational Health | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Public, Environmental & Occupational Health | Zone 1 |
| Minor | Infectious Diseases | Zone 2 |
| Minor | Microbiology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
| Minor | Microbiology | Zone 2 |
| Minor | Public, Environmental & Occupational Health | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.14LetPub ·
- Impact factor (publisher) 2025
- 5.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.7Publisher website ·
- CiteScore 2026-06
- 8.4LetPub ·
- SJR 2026-06
- 1.31LetPub ·
- SNIP 2026-06
- 1.84LetPub ·
- h-index
- 24LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 1,259OpenAlex ·
- 2-year mean citedness
- 4.92OpenAlex ·
- Self-citation rate
- 5.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 166LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 2,300,000Publisher website ·
Articles by year OpenAlex count · 2,800 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 140 | 140 | 46 |
| 2025 | 173 | 173 | 669 |
| 2024 | 157 | 157 | 1,597 |
| 2023 | 149 | 149 | 2,716 |
| 2022 | 165 | 165 | 4,273 |
| 2021 | 207 | 207 | 6,126 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
148 daysMedian, submission to acceptance · P25–P75 89 days – 209 days
- Acceptance to online
- median 18 days (106 articles)
- Submission to online
- median 170 days
- Sample
- 106 articles with submission and acceptance dates (361 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,790 / USD 3,290 / GBP 2,390 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,290 / EUR 2,790 / GBP 2,390 | — | — | |
| LetPub | GBP 2,190 / USD 3,090 / EUR 2,590 | Yes | — | |
| Publisher website | GBP 2,390 / USD 3,290 / EUR 2,790 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare2 items from the author guidelines
- Suggested reviewers
- Optional
- Not considered
- Clinical diagnosis or treatment of infectious diseases.
Article types accepted8
- brief reportResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
- case reportResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
- commentResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
- correspondenceResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
- guidelineResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
- meeting reportResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
- researchResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
- reviewResearch Case report Comment Guideline Correspondence Meeting report Review Brief reportLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data sharing strongly encouraged or required; deposit in public repositories where appropriate; 'Availability of data and materials' section required. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Antimicrobial Resistance & Infection Control articles are published open access under a CC BY-NC-ND (Creativ…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Authors may suggest peer reviewers in cover letter. Model summary
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2012
- ISSN
- 2047-2994
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Antimicrobial Resistance and Infection Control
What CAS zone is Antimicrobial Resistance and Infection Control in?
In the 2025 upgraded edition of the CAS Journal Ranking, Antimicrobial Resistance and Infection Control is in Zone 2 of Medicine, and in Zone 2 of the minor category Infectious Diseases / Microbiology / Public, Environmental & Occupational Health. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Antimicrobial Resistance and Infection Control?
The latest impact factor listed by LetPub is 5.14; CiteScore 8.4, h-index 108.
How long does peer review take at Antimicrobial Resistance and Infection Control?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 148 days (interquartile range 89–209 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Antimicrobial Resistance and Infection Control based?
Of the 74 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (12), Switzerland (9) and United Kingdom (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Antimicrobial Resistance and Infection Control?
According to LetPub and DOAJ records, Antimicrobial Resistance and Infection Control is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Antimicrobial Resistance and Infection Control open access, and what is the APC?
Antimicrobial Resistance and Infection Control is a fully open-access journal. APC about USD 3,290.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .